Form 4: Liquidia CEO Roger Jeffs Plans Future Stock Transactions

Liquidia Corp CEO Roger Jeffs filed a Form 4 detailing future equity award vesting and a pre-planned stock sale to cover tax obligations.

Summary

• Roger Jeffs, Liquidia Corp's Chief Executive Officer and Director, filed a Form 4 reporting planned transactions under a Rule 10b5-1 plan.
• On October 10, 2025, 13,834 Performance Stock Units (PSUs) are scheduled to convert into common stock on a one-for-one basis, increasing his direct beneficial ownership.
• These PSUs are part of a grant of 221,338 PSUs made on January 11, 2024, of which 96,836 have vested as of the filing date, with 124,502 remaining unvested from this specific grant.
• On October 13, 2025, Jeffs plans to sell 20,261 shares of common stock at a price of $23.41 per share.
• This sale is intended to cover tax liabilities associated with the settlement of previously granted Restricted Stock Units (RSUs) and PSUs from January 11, 2023, and January 11, 2024.
• Following these transactions, Jeffs' direct beneficial ownership will be 1,032,973 shares.
• He also holds indirect beneficial ownership of 46,595 shares through the Roger A. Jeffs Living Trust and 1,541,667 shares through Serendipity BioPharma LLC.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While there is a planned sale of shares, it is for tax purposes and pre-scheduled under a 10b5-1 plan, which is a neutral event. The vesting of PSUs is a positive indicator of executive compensation and alignment with shareholder interests.

Positives

• The vesting of 13,834 Performance Stock Units (PSUs) on October 10, 2025, indicates continued equity compensation for the CEO, aligning his interests with shareholders.
• The transactions are pre-planned under a Rule 10b5-1 plan, demonstrating transparency and mitigating concerns about opportunistic insider selling.

Negatives

• The planned sale of 20,261 shares, even for tax purposes, will slightly reduce the CEO's direct beneficial ownership in the company.

Future Outlook

The CEO has significant unvested equity awards, including 90,469 unvested RSUs from a January 2023 grant, 124,502 unvested RSUs from a January 2024 grant, and 229,327 RSUs from a January 2025 grant, which are expected to vest over time according to their respective schedules.

Industry Context

This Form 4 filing details routine insider stock transactions, specifically the vesting of equity awards and a tax-related sale, which are common occurrences for executives in publicly traded companies across all industries. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Roger Jeffs holds 46,595 shares indirectly through the Roger A. Jeffs Living Trust UAD 2/29/2000, where he is the trustee.
• He also holds 1,541,667 shares indirectly through Serendipity BioPharma LLC, where he is a manager with sole voting and dispositive power.

Stakeholder Impact

• Shareholders: The planned transactions are routine and pre-scheduled, suggesting no immediate material impact on company strategy or performance. The CEO's continued equity holdings maintain alignment of interests.
• Employees: No direct impact mentioned.

Next Steps

• Continued vesting of remaining unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) according to their respective schedules.
• Potential future sales of shares to cover tax obligations upon subsequent vesting events.

Key Dates

Keywords

Liquidia Corp, LQDA, Roger Jeffs, CEO, Insider Trading, Form 4, Stock Sale, Equity Awards, PSUs, RSUs, 10b5-1 Plan